Insufficient access to oral paediatric medicines in Ghana: A descriptive study

Daniel N A Ankrah1,2, Joseph T Turkson3, Edith B Boateng4

  • 1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands. D.Ankrah@uu.nl.

Insights

This study found that many commonly prescribed pediatric medicines are unavailable in Ghana, requiring extemporaneous preparation. Some of these essential children's medicines lacked WHO approval or local registration, highlighting safety concerns.

Area of Science:

  • Pharmacology
  • Paediatric Medicine
  • Public Health

Background:

  • Children face significant healthcare access challenges, particularly concerning medication availability.
  • Off-label prescription of pediatric medicines can lead to serious safety issues.
  • This study focuses on frequently prescribed children's medicines that are not readily available in Ghana and are prepared extemporaneously.

Purpose of the Study:

  • To identify frequently prescribed pediatric medicines that require extemporaneous preparation in Ghana.
  • To assess the availability and regulatory status of these essential children's medicines.
  • To highlight potential safety concerns associated with unlisted or unregistered pediatric medications.

Main Methods:

  • Prescriptions for extemporaneous oral preparations for children at Korle-Bu Teaching Hospital were analyzed (November 2013 onwards).
  • Data collected included medicine name, dosage, and prescribing facility.
  • Medicines were cross-referenced with the World Health Organization Children's Medicine List and registered with the Food and Drugs Authority, Ghana.

Main Results:

  • A total of 622 prescriptions for 35 different pediatric formulations were processed.
  • Some prescribed medicines (e.g., Baclofen, Clonazepam) were not on the WHO Children's Medicine List or registered in Ghana.
  • The majority of prescribed medicines (88.6%) were for non-communicable diseases.

Conclusions:

  • Pediatric prescriptions, including off-label medications, are frequently prepared extemporaneously in Ghana.
  • Urgent measures are needed to improve access to essential pediatric medicines.
  • Enhanced monitoring of benefit-risk profiles for pediatric medicines is crucial for better treatment outcomes in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
652
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
698
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
968